News for 'pharmaceuticals'

Subhash Dandekar: The man who brought colours to artists and students!

Subhash Dandekar: The man who brought colours to artists and students!

Rediff.com17 Jul 2024

Subhash Dandekar, chairman emeritus of Kokuyo Camlin and the man known for bringing colours to artists as well as students in the country, passed away on Monday at 85.

High-level delegation of US pension funds to visit India next week

High-level delegation of US pension funds to visit India next week

Rediff.com6 Sep 2024

A delegation of high-level executives from US public pension funds (non-profit and government sectors) is visiting India next week to assess and familiarise themselves with the investment opportunities in the country. These executives belong to various American states and cumulatively represent $1.8 trillion in assets under management (AUM) invested across the US and global markets. The United States (US) mission to India, which includes its embassy and consulates and the Department of Treasury, along with India's Ministry of Finance and the National Investment and Infrastructure Fund (NIIF), is hosting the delegation.

India To Fast-Track Visas For Chinese Nationals

India To Fast-Track Visas For Chinese Nationals

Rediff.com8 Aug 2024

The new guidelines, effective from August 1, aim to expedite visa approvals for nationals from China and other countries sharing land borders with India.

Markets Expected To Remain Volatile

Markets Expected To Remain Volatile

Rediff.com4 Oct 2024

'As the markets are expected to remain jittery in the near term, we advise investors to use this opportunity to enter quality largecaps from a long-term perspective.'

Modiji Blesses Anant-Radhika

Modiji Blesses Anant-Radhika

Rediff.com14 Jul 2024

Prime Minister Narendra D Modi on Saturday blessed the newly wed couple Anant Ambani and Radhika Merchant after their wedding that was attended by global celebrities, business tycoons and politicians.

Is A Toxic Work Culture Affecting You?

Is A Toxic Work Culture Affecting You?

Rediff.com20 Sep 2024

"There is a limit when it comes to tolerating abusive behaviour or working styles. Many (employees) find ways to quit," says career coach and rediffGURU Pradeep Pramanik.

AI Disruption Is REAL & Happening FAST!

AI Disruption Is REAL & Happening FAST!

Rediff.com28 Aug 2024

When AI is used to enhance operational efficiency, businesses can deliver the same product or service but with improved quality, faster, or even at a reduced cost

Emami has built itself through acquisition, but...

Emami has built itself through acquisition, but...

Rediff.com8 Oct 2024

Two young men jostle in a rickshaw as it clatters along a narrow, bustling lane of North Kolkata, each with a leg dangling over the side of the vehicle, a bulging sack of cosmetics nestled between them. The protagonists here are the founders of Emami - Radhe Shyam Agarwal and Radhe Shyam Goenka - childhood friends who gave up cushy corporate jobs to build a fast-moving consumer goods (FMCG) company. From a 200-square-foot rented space on Muktaram Babu Street in North Kolkata, brand Emami stepped into the competitive world of FMCG 50 years back, armed with just three products: Vanishing cream, talcum powder, and cold cream.

'Always Treat China With Caution'

'Always Treat China With Caution'

Rediff.com7 Nov 2024

'Given China's past behaviour and their territorial claims, should we be sceptical regarding China's willingness to adhere to these agreements fully? The answer is yes.' 'As Ronald Reagan famously said in the context of the SALT talks, 'Trust, but verify!' India should also do the same.' 'This has already begun with foot patrolling, drones, satellite imagery and so on. India's military deployment did mirror China's and will continue to do so in the future.'

'PLI Has Been A Big Boost To Manufacturing'

'PLI Has Been A Big Boost To Manufacturing'

Rediff.com26 Sep 2024

'We can hope to see a lot of creation of jobs in the days to come.'

Govt cuts customs duty on 3 cancer drugs

Govt cuts customs duty on 3 cancer drugs

Rediff.com23 Jul 2024

The government proposes to cut custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil.

Pill Review: Impressive Riteish!

Pill Review: Impressive Riteish!

Rediff.com12 Jul 2024

Riteish Deshmukh makes this medical drama watchable! exclaims Namrata Thakker.

Budget may go vocal for higher local procurement

Budget may go vocal for higher local procurement

Rediff.com17 Jul 2024

To boost domestic manufacturing under the Make in India initiative and reduce dependency on imports, the government is expected to announce in the Budget an increase in the minimum local content requirement for public procurement, with certain sectors being granted exceptions. Currently, firms producing goods, services, or works with at least 50 per cent local content are classified as Class-I local suppliers and are preferred the most in government procurement.

Ambanis Own 10% of India's Wealth

Ambanis Own 10% of India's Wealth

Rediff.com9 Aug 2024

The Adani family, led by Chairman Gautam Adani, is the most valued first-generation family business at Rs 15.44 trillion.

Mpox Puts Health System On High Alert

Mpox Puts Health System On High Alert

Rediff.com17 Aug 2024

Strict screening protocols are to be implemented for passengers arriving from central African countries affected by the outbreak.

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Ready For Some Fantasy OTT?

Ready For Some Fantasy OTT?

Rediff.com12 Jul 2024

Fantasy and road trips rule OTT this week. Sukanya Verma gives you options to take your pick from.

Electronics exports propelled by mobile show sharpest surge in top 10 club

Electronics exports propelled by mobile show sharpest surge in top 10 club

Rediff.com3 Jan 2024

Exports of electronics goods has risen by 24 per cent from April to November as compared with the same period in the last fiscal, the largest increase out of India's top 10 export categories. The increase has been propelled by mobile exports under the Production Linked Incentive (PLI) scheme and has pushed electronics up from sixth to fifth position in the top 10. A gap of $200 million separates electronics from occupying the fourth position, currently held by drugs and pharmaceuticals at $17.9 billion.

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Rediff.com3 Oct 2023

India's pharmaceutical exports to Iran have been hit owing to depleting rupee reserves in the West Asian country because of India stopping the import of crude oil from it in 2019 following US sanctions. Pharmaceutical exports dropped 71.25 per cent in April-August this year over the same period last year. The data from the Pharmaceutical Exports Promotion Council (Pharmexcil) showed exports to Iran had declined 31.29 per cent in 2022-23 as against the previous financial year.

Nifty expected to reach 24,500 level by Dec 2024

Nifty expected to reach 24,500 level by Dec 2024

Rediff.com28 May 2024

With an expected earnings growth of 15 per cent, benchmark index Nifty 50 may hit 24,500 level by December 2024 and move further to surpass the level of 26,500 by December 2025, Emkay Investment Managers said on Tuesday. The 50-share Nifty settled at 22,888.15 on Tuesday. In the previous day, it hit a new lifetime peak of 23,110.80.

Mankind Pharma to lead in Indian women's health market after BSV deal

Mankind Pharma to lead in Indian women's health market after BSV deal

Rediff.com29 Jul 2024

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women's health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to acquire Bharat Serums and Vaccines (BSV), senior company officials said. The deal potentially opens doors for Mankind Pharma to the overseas markets, which currently draws 92 per cent of its revenues from India. The combined entity will draw around 13 per cent revenues from the international market, with the remaining coming from the domestic market.

Not just China, all PLI-led visas being fast-tracked: Piyush Goyal

Not just China, all PLI-led visas being fast-tracked: Piyush Goyal

Rediff.com1 Jul 2024

The government is expediting visa-related issues to bring technicians to India from any country, not just China, as and when required, to ensure the smooth implementation of the flagship production-linked incentive (PLI) scheme aimed at boosting domestic manufacturing. "If those under the PLI scheme need to get their equipment installed, we try to expedite the ability to get technicians into India from any country, whichever it may be," Union Commerce and Industry Minister Piyush Goyal told Business Standard in an interview.

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Rediff.com23 May 2024

Several firms are stepping up to help their workforce cope with soaring temperatures

India's First Dengue Vaccine Likely To Be Ready By 2026

India's First Dengue Vaccine Likely To Be Ready By 2026

Rediff.com30 Jul 2024

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024.

India Inc earnings slow down in Q1FY25 despite margin gains

India Inc earnings slow down in Q1FY25 despite margin gains

Rediff.com23 Aug 2024

After four years of high double-digit growth in profits, corporate earnings of Indian companies hit a speed bump in the April-June quarter of 2024 (Q1FY25), leading to the risk of a downward revision in India Inc profit estimates for FY25 and volatility in the equity market. Earnings growth slowed despite companies in most non-financial sectors reporting higher operating margins from lower commodity prices and a decline in interest costs.

India's exports rise 11.9% in Feb, highest in 11 months

India's exports rise 11.9% in Feb, highest in 11 months

Rediff.com15 Mar 2024

India recorded the highest monthly exports during the fiscal in February, registering an 11.9 per cent growth to $41.4 billion, mainly driven by increased shipments of engineering goods, electronic items and pharma products. The trade deficit during February worked out to $18.7 billion, up from $16.57 billion in the year-ago month, as gold imports surged significantly. Merchandise imports were valued at $60.11 billion, up 12.16 per cent compared to $53.58 per cent in February 2023.

AstraZeneca's COVID-19 Vaccine: The TTS Factor

AstraZeneca's COVID-19 Vaccine: The TTS Factor

Rediff.com1 May 2024

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.'

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Why Promoters Are Cutting Stake In Companies

Why Promoters Are Cutting Stake In Companies

Rediff.com26 Jun 2024

'This trend will continue as long as the bull run continues.'

How year's most extravagant wedding was made secure

How year's most extravagant wedding was made secure

Rediff.com14 Jul 2024

Three different invitations were sent out for the wedding and the receptions with top-run guests being sent a large red box that contained an intricate chest incorporating a mini silver temple featuring gold idols of various Hindu deities, including Lord Ganesh, Radha-Krishna, and Goddess Durga.

Domestic pharma market grew by 6.8% in 2023

Domestic pharma market grew by 6.8% in 2023

Rediff.com22 Jan 2024

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. This indicates the price increase has been the major growth driver. Growth in the moving annual turnover (the previous 12 months' turnover) in December was 5.1 per cent and that in new product introduction 2.6 per cent, while volumes dipped 0.9 per cent, leading to an overall growth rate of 6.8 per cent, according to the data from market research firm Pharmatrac.

Nifty cos' profit growth seen at slowest in 5 qtrs

Nifty cos' profit growth seen at slowest in 5 qtrs

Rediff.com16 Apr 2024

The brokerage earnings estimate for the January-March 2024 quarter (Q4FY24) for Nifty 50 companies hints at a slowdown in corporate profit growth while revenue increase is likely to be in low single digits as in the previous two quarters. According to various brokerage estimates, the companies' combined net profits are expected to grow 3.1 per cent year-on-year (Y-o-Y) in Q4FY24, the slowest in the last five quarters. For comparison, the index companies' combined net profits were up 8.2 per cent Y-o-Y in Q3FY24 and 3.4 per cent Y-o-Y in Q4FY23.

India's exports dip marginally in March; 3.11% in FY24

India's exports dip marginally in March; 3.11% in FY24

Rediff.com15 Apr 2024

India's merchandise exports dipped marginally in March to $41.69 billion, and by 3.11 per cent during the last fiscal year to $437.06 billion mainly due to continued geopolitical turmoil, and depressed global trade. Imports, too, declined in March as well during the entire 2023-24. Trade deficit, or the gap between imports and exports, narrowed 17.74 per cent in March to $15.6 billion and came down 9.33 per cent to $240.17 billion in FY24.

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

Rediff.com11 Jun 2024

The market regulator's newly proposed selection criteria for the over Rs 400-trillion-a-day futures and options (F&O) market could pave the way for the entry of popular stocks such as Life Insurance Corporation (LIC) of India, Jio Financial Services, Zomato, Paytm, DMart, and Adani Energy into the derivatives segment. The Indian derivatives market, which accounts for most of the trading volumes, could see big churn with over two dozen exits from the current list of 182 stocks due to an upward revision in the eligibility thresholds.

Companies bribed parties via electoral bonds for projects: Prashant Bhushan

Companies bribed parties via electoral bonds for projects: Prashant Bhushan

Rediff.com12 May 2024

He said a petition has been filed before the Supreme Court, seeking an independent probe by a special investigation team into the alleged nexus between political parties and companies for corruption through electoral bonds.

Capital Gains Tax Tinkering May Spook Markets

Capital Gains Tax Tinkering May Spook Markets

Rediff.com10 Jul 2024

'Expectations are high regarding the change in LTCG with respect to equity investments.'

Why Dolo, Saridon, Calpol Will Have QR Codes

Why Dolo, Saridon, Calpol Will Have QR Codes

Rediff.com8 Aug 2023

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Rediff.com9 Aug 2024

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'

Will Modi push for Ukraine truce in Tuesday's talks with Putin?

Will Modi push for Ukraine truce in Tuesday's talks with Putin?

Rediff.com8 Jul 2024

Prime Minister Modi will hold in-person meetings with President Putin for 8-9 hours during his nearly 24-hour stay in Russia, they said.

Exports up 9% in May; trade deficit widens to 7-month high

Exports up 9% in May; trade deficit widens to 7-month high

Rediff.com14 Jun 2024

India's merchandise exports rose by 9.1 per cent to $38.13 billion in May even as the trade deficit widened to a seven-month high of $23.78 billion during the month, according to government data. Healthy growth in sectors, such as engineering, electronics, pharmaceuticals, textiles and plastics helped register growth in exports despite global economic uncertainties.